Share |

innovation

Why the rise of new money is driving a surge in Asian family offices

April 25, 2023

Jefferson Sun, founder and CEO of Fargo Wealth Group, talks about how the past ten years have been a golden decade for Chinese entrepreneurs and what local governments are doing to help establish a raft of new family offices as a result.

Having seen a rise in demand for flexibility within a traditionally rigid banking system, Fargo Wealth Group was established to offer a wide range of expertise to ultra-high-net-worth (UHNW) individuals and families - from wealth management to asset management and family office services to FinTech innovation.

How TechBio is speeding up clinical trials and cutting through red tape

April 13, 2023

Hanadi Jabado, managing partner at innovation investment fund Sana Capital, talks about how independent thinking and positive change is making medical advancement faster and more effective.

The traditional route from innovative ideation to hitting the market is littered with bottlenecks and bureaucracy. However, Hanadi Jabado, managing partner at innovation investment fund Sana Capital, is extolling the virtues of TechBio’s cost-and-time-cutting benefits.

Here, she talks about how independent thinking and positive change is making medical advancement faster and more effective.

Dr. David Brown: How Viagra opened the doors to machine learning innovation

March 17, 2023

In an exclusive interview with Campden FB, Dr. David Brown talks about his passion for entrepreneurialism, the mind-blowing benefits of machine learning and how big pharma needs a change in mindset…

Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.

While working for Pfizer, he was named co-inventor on the patent for Viagra and, for eight years, led the team that developed the hugely successful erectile dysfunction medication into one of the bonanza breakthroughs of the century.

Tech Bio: Why data-driven technologies are the way forward

February 16, 2023

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes. Here, she talks to Campden FB about starting the medical and cost-efficient benefits of Tech Bio and the rising importance of ‘data donation’…

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes.

A managing partner at innovation investment fund Sana Capital, Hanadi is a passionate advocate for global information sharing and firmly believes the time is now for private investment in early-stage companies that are set to positively shape the future of healthcare.

Why are family offices increasing sustainable investing?

November 30, 2022

An increased consideration of environmental, social and governance (ESG) factors, innovations in technology and a next-gen-driven desire to do better for the world are seen as motivating factors for family offices increasing their commitment to sustainable investment, according to Campden Wealth and Raffles Family Office’s Asia-Pacific Family Office Report 2022.

Venture capital: Ensuring meaningful impact and return on investment

June 23, 2022

Strategic leader Hanadi Jabado talks about how her impactful investment strategy can do good and do well.

Hanadi Jabado is a passionate advocate for entrepreneurship and innovation. When she relocated to the Cambridge ecosystem, her exposure to the best of tech in Europe allowed her to develop a skill for understanding and explaining the needs of early-stage ventures. With successful investments across diverse sectors, she has since seen many startups go on to great things.

Why the white-hot VC market is nothing like the dot com-era boom and bust

May 5, 2022

A global surge in start-up funding has prompted some commentators to draw comparisons with the dotcom boom and bust at the turn of this century. A cursory glance at the numbers does hint at some parallels says private markets investment platform Titanbay.

The disruptive medtech company aiming to minimise patients’ need for invasive mechanical ventilation intervention

April 4, 2022

INSPIRA is developing a cost-effective respiratory support system which will function as an artificial lung for deteriorating respiratory patients. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and co-founder Joe Hayon explains the benefits and potential future applications of the system.

INSPIRA is an innovative medical device company which is developing the ART system, a cost-effective early extracorporeal respiratory support system which will function as an artificial lung for deteriorating respiratory patients.

The ART system utilises a new approach based on hemo-protective technology aimed at rebalancing oxygen saturation levels while patients are awake and breathing, potentially minimising the patient's need for invasive mechanical ventilation intervention.

How a ground-breaking school curriculum is preparing students to make positive change through technology

March 18, 2022

With a well-earned reputation for being one of the world’s finest boarding schools, the Institut auf dem Rosenberg has long instilled entrepreneurial skills and attitudes in its students. Now, with a new cutting-edge program teaching the benefits of technology, they’re preparing the next generation for whatever the 21-Century has in store.

Humanix is the first curriculumin the world to train students' cognitive capacities and literacy through the study of human connectiveness.

Fearless entrepreneur: Werner Tschollar on breakthroughs in biotech and staying small and flexible in business

February 16, 2022

For nearly three decades, Dr. Werner Tschollar has been at the forefront of the pharmaceutical, biotech and financing industries. With a humanitarian approach to life and a savvy head for business, he has parlayed his extensive credentials and experience into a series of innovative products and treatments that have changed the quality of life for countless people.